HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{Under Construction}} | {{Under Construction}} | ||
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023- | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]]. | ||
}}</blockquote> | }}</blockquote> | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
| Line 14: | Line 14: | ||
==Cancer Category / Type== | ==Cancer Category / Type== | ||
*[[Mature T- and NK-cell Neoplasms|Mature T- and NK-cell Neoplasm]] | *[[HAEM4:Mature T- and NK-cell Neoplasms|Mature T- and NK-cell Neoplasm]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
*[[Intestinal T-cell Lymphoma]] | *[[HAEM4:Intestinal T-cell Lymphoma]] | ||
==Definition / Description of Disease== | ==Definition / Description of Disease== | ||
| Line 172: | Line 172: | ||
|'''STAT3-JAK2 fusion''' | |'''STAT3-JAK2 fusion''' | ||
|'''Likely role in diagnosis (inclusion)''' | |'''Likely role in diagnosis (inclusion)''' | ||
|Likely present in CD4+ GI TLPD and absent in [[Enteropathy- | |Likely present in CD4+ GI TLPD and absent in [[HAEM5:Enteropathy-associated T-cell lymphoma|EATL]], [[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|MEITL]], and other T-cell lymphomas<ref name=":0" /> | ||
|- | |- | ||
|EBV | |EBV | ||
| Line 429: | Line 429: | ||
==Links== | ==Links== | ||
*[[Intestinal T-cell Lymphoma]] | *[[HAEM4:Intestinal T-cell Lymphoma]] | ||
==References== | ==References== | ||